ResMed Inc.'s New S+ Consumer Sleep Monitor Now Integrates With Apple HealthKit
SAN DIEGO, Nov. 18, 2014 /PRNewswire/ -- ResMed (NYSE: RMD), a leading innovator in sleep, recently launched the all-new S+, the world's first non-contact, personal sleep monitoring device. ResMed today announced S+ availability through Apple retail stores in the United States and from the Apple Online Store (www.apple.com). The free S+ by ResMed App now integrates with Apple HealthKit in iOS8 to give consumers an easy-to-read, daily snapshot of their overall health and fitness. The user report can also be shared with health care providers.
"By integrating S+ with HealthKit, we're able to provide an easy way for Apple users to track, share and improve their own sleep habits," said Don Darkin, president, ResMed Sleep-Disordered Breathing business unit. "S+ is a sleek, portable, bedside device that tracks a person's sleep. When paired with Apple HealthKit, S+ provides a daily sleep score that can be viewed and shared in the same manner as calories, steps walked or miles ran."
S+ by ResMed sends sleep results, such as sleep patterns over time, hours slept during particular sleep cycles, and nightly sleep scores from 0 to 100, directly to Apple's Health App so the two become seamlessly integrated to give users a holistic view of their own sleep patterns and wellbeing. Should they choose to, S+ also offers consumers a quick and efficient way to share their sleep habits with physicians and healthcare providers.
S+ by ResMed is now available for the suggested retail price of $149.99 at Apple, Bed Bath & Beyond® and Best Buy retail stores in the United States, from the Apple Online Store (www.apple.com), and online at mySplus.com.
The S+ by ResMed App is available for free from the App Store on iPhone or at www.AppStore.com.
S+ by ResMed is the world's first non-contact sleep system that uses patented bio-motion sensors to measure an individual's sleep stages and environment, and deliver personalized feedback that helps improve sleep from the very first night.
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.
For News Media
Global Corporate Communications
Senior Director, Investor Relations
SOURCE ResMed Inc.